| 03 Sept, 02:35 pm | other | 0 | Piramal Pharma Limited received an ESG rating, a routine third-party recognition with no investor impact. | nse |
| 26 Aug, 05:21 pm | — | … | Piramal Pharma Ltd - 543635 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 24 Aug, 05:08 pm | — | … | Sustainability Report of Piramal Pharma Limited ( the Company ) for thefinancial year 2025-26-26 | nse |
| 18 Aug, 11:38 am | — | … | Piramal Pharma Limited has informed the Exchange about Acquisition | nse |
| 18 Aug, 11:34 am | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 18 Aug, 11:29 am | — | … | Piramal Pharma Ltd - 543635 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 10 Aug, 06:09 pm | — | … | Piramal Pharma Limited has informed the Exchange regarding 'Exercise of call option for acquisition of additional equity stake in Yapan Bio PrivateLimited'. | nse |
| 10 Aug, 06:02 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement Under Regulation 30 (LODR)- Exercise Of Call Option For Acquisition Of Additional Equity Stake In Yapan Bio Private Limited | bse |
| 10 Aug, 02:26 pm | — | … | Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 03 Aug, 05:36 pm | — | … | Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Resumption of operations at Company s facilities located at Ahmedabad, Gujarat | nse |
| 31 Jul, 03:11 pm | — | … | Piramal Pharma Limited has informed the Exchange about Transcript | nse |
| 31 Jul, 03:04 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 30 Jul, 12:25 pm | — | … | Piramal Pharma Limited has informed the Exchange about Link of Recording | nse |
| 30 Jul, 12:17 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 29 Jul, 09:01 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 29 Jul, 08:58 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 29 Jul, 08:54 pm | — | … | Piramal Pharma Limited has informed the Exchange about Presentation | nse |
| 29 Jul, 08:51 pm | — | … | Piramal Pharma Limited has informed the Exchange about Investor Presentation | nse |
| 29 Jul, 08:51 pm | — | … | Piramal Pharma Ltd - 543635 - Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended 30Th June, 2026 | bse |
| 29 Jul, 08:49 pm | — | … | Piramal Pharma Limited has informed the Exchange regarding a press release dated July 29, 2026, titled "Piramal Pharma Limited Announces Results for Q1 FY27". | nse |
| 29 Jul, 08:45 pm | — | … | Piramal Pharma Ltd - 543635 - Board Meeting Outcome for Outcome Of Board Meeting Of Piramal Pharma Limited Held On 29Th July, 2026 | bse |
| 29 Jul, 08:44 pm | — | … | Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | nse |
| 29 Jul, 05:19 pm | — | … | Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 -Grant of stock options pursuant to Piramal Pharma Limited - Employee Stock Option and Incentive Plan 2022 | nse |
| 24 Jul, 08:55 pm | — | … | Please refer attachment. | nse |
| 24 Jul, 08:42 pm | — | … | Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Temporary Suspension Of Operations At Company'S Facilities Located At Ahmedabad, Gujarat. | bse |
| 20 Jul, 12:33 pm | — | … | Piramal Pharma Ltd - 543635 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For Quarter Ended 30Th June, 2026. | bse |
| 17 Jul, 10:47 am | — | … | Piramal Pharma Ltd - 543635 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 09 Jul, 10:57 am | — | … | Successful closure of US FDA Inspection at Piramal Pharma s manufacturing facility located at Sellersville (USA) facility | nse |
| 09 Jul, 10:53 am | — | … | Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 03 Jul, 05:21 pm | — | … | Business Responsibility & Sustainability Report for the financial year 2025-26 | nse |
| 03 Jul, 03:31 pm | — | … | Piramal Pharma Ltd - 543635 - Reg. 34 (1) Annual Report. | bse |
| 29 Jun, 07:45 pm | — | … | Ajay G. Piramal has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 23 Jun, 04:37 pm | — | … | The Exchange has sought clarification from Piramal Pharma Limited with respect to recent news item captioned Piramal Pharma Share Price Spikes Over 10% - What Is Driving The Rally?. The response from the Company is attached. | nse |
| 23 Jun, 01:10 pm | — | … | The Exchange has sought clarification from Piramal Pharma Limited with respect to recent news item captioned Piramal Pharma Share Price Spikes Over 10% - What Is Driving The Rally?. The response from the Company is awaited. | nse |
| 03 Jun, 11:05 am | — | … | Permanent revocation of closure directions for Company s Dahej Site | nse |
| 03 Jun, 10:59 am | — | … | Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 01 Jun, 12:04 pm | — | … | Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 22 May, 06:11 pm | — | … | Piramal Pharma Ltd - 543635 - Compliances-Reg.24(A)-Annual Secretarial Compliance | bse |
| 19 May, 02:08 pm | — | … | Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 18 May, 11:44 am | — | … | Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Successful closure of US FDA Inspection at Piramal Pharma s manufacturing facility located at Digwal, Telangana, India | nse |
| 10 May, 10:26 pm | — | … | Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 04 May, 03:21 pm | — | … | Intimation of Schedule of Analyst/ Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 30 Apr, 02:52 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 30 Apr, 02:46 pm | — | … | Transcript of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2026 | nse |
| 29 Apr, 04:51 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 29 Apr, 04:50 pm | — | … | Contact details of Key Managerial Personnel as required under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 | nse |
| 29 Apr, 04:45 pm | — | … | Audio Recording of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2026 | nse |
| 29 Apr, 04:33 pm | — | … | Audio Recording of Conference Call on the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March, 2026 | nse |
| 28 Apr, 09:39 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Change in Registered Office Address | bse |
| 28 Apr, 09:36 pm | — | … | Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Cessation | bse |